CClinicalTrials.gg
Status unknownNCT04964154BRAVEUpdated Jul 15, 2021

Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study

An interventional study of Protect Your Elders Campaign in Covid19 Virus Infection, sponsored by North Carolina Central University. Status unknown at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-15.

Sponsored by North Carolina Central University · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Feb 2021, registered Jul 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
4,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.

02

Conditions studied

  • Covid19 Virus Infection

Browse trials for

Keywords

  • COVID-19 testing
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 4,000 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

North Carolina Central University is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Self reports as Native American or American Indian

Exclusion criteria

Exclusion Criteria:

  • Does not self-report as Native American or American Indian
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
4,000 participants (estimated)

Study arms

  • No intervention
    BRAVE Non-Intervention

    Survey participants in the BRAVE non-intervention arm will not have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.

  • Active comparator
    BRAVE Intervention

    Survey participants in the BRAVE intervention arm will have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.

    Behavioral: Protect Your Elders Campaign

Interventions

  • BehavioralProtect Your Elders Campaign

    This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.

06

What researchers measure

Primary outcomes

  1. Increase in COVID-19 testing

    Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get tested for COVID-19.

    Time frame: 1 month

  2. Increase in COVID-19 vaccination

    Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get vaccinated against COVID-19.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • Lumbee Tribe Tribal Housing Complex
    Pembroke, North Carolina 28372, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04964154
Lead sponsor
North Carolina Central University
Collaborators
Lumbee Tribe of North Carolina, University of North Carolina at Pembroke
Responsible party
Deepak Kumar (Director of Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University) — Principal investigator
First posted
Jul 15, 2021
Start date
Feb 17, 2021
Primary completion
Mar 30, 2022 (estimated)
Completion
Jun 30, 2022 (estimated)
Last update
Jul 15, 2021

Study contacts

Deepak Kumar, PhD
Contact
dkumar@ad.nccu.edu
919-530-7017
Tracie Locklear
Contact
tlockl12@nccu.edu
9195306251
Deepak Kumar, PhD
principal investigator · North Carolina Central University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion